Syschem (India) MD, chairman, board of directors and AGM
BSE: 531173Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹32.68.
- Next results date: the board meets on 26 Oct 2026 to consider: quarterly results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹166 Cr2,342nd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Earlier quarters restated in the year
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet.
- Shares changed
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 4 Aug 2026
- 11.7%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 25 May 2026
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day.
- 17,030
Syschem (India) board of directors
At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares
- Managing directorSuninder Veer Singh
- ChairpersonArshdeep Kaur
6 directors3 independent2 executive1 non-executive
- Ranjan JainExecutive · joined Jan 2015 · reappointed Sep 2026 · 1 listed board · 1 committee seat
- Suninder Veer Singh · Managing directorExecutive · joined Dec 2016 · reappointed Sep 2026 · 1 listed board · 1 committee seat
- Arshdeep Kaur · ChairpersonIndependent · joined Nov 2022 · 47 months as independent · 2 listed boards · 2 as independent · 4 committee seats, 1 as chair
- Renu RawatIndependent · joined Nov 2022 · 47 months as independent · 1 listed board · 1 as independent · 2 committee seats, 1 as chair
- Madan Lal AggarwalIndependent · joined Nov 2024 · 22 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
- Sunil Kumar BhasinNon-executive · joined Mar 2025 · 18 months as independent · 1 listed board · 1 committee seat, 1 as chair
An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.
1 director who left
- Vivek Trehan, left 24 Mar 2025: Others
Committees and meetings
Who sits on each, and how often they met.Board meeting notices and outcomes
Board
- 1 Sep 20266 of 6 present3 independent · 27 days in between
- 4 Aug 20266 of 6 present3 independent · 17 days in between
- 17 Jul 20266 of 6 present3 independent · 9 days in between
- 7 Jul 20266 of 6 present3 independent · 14 days in between
3 earlier meetings
- 22 Jun 20266 of 6 present3 independent · 18 days in between
- 3 Jun 20266 of 6 present3 independent · 8 days in between
- 25 May 20266 of 6 present3 independent
Audit Committee
Chair Arshdeep Kaur
Renu Rawat, Madan Lal Aggarwal, Sunil Kumar Bhasin
- 1 Sep 20264 of 4 present3 independent · 27 days in between
- 4 Aug 20264 of 4 present3 independent · 70 days in between
- 25 May 20264 of 4 present3 independent
Nomination and remuneration committee
Chair Renu Rawat
Arshdeep Kaur, Madan Lal Aggarwal, Sunil Kumar Bhasin
- 1 Sep 20264 of 4 present3 independent · 89 days in between
- 3 Jun 20264 of 4 present3 independent
Stakeholders Relationship Committee
Chair Madan Lal Aggarwal
Ranjan Jain, Suninder Veer Singh
- 1 Sep 20263 of 3 present1 independent
Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.
Statutory auditor
Named in the results for the quarter to Mar 2026.
- STAV& CoPeer-review certificate valid to Aug 2026
1 earlier auditor
- STAV & CoNamed in the filing for the quarter to Dec 2025
A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.
Syschem (India) AGM and shareholder votes
Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Syschem (India) share news and announcements
Annual general meeting, 30 Sep 2026
13,194 shareholders on the register on 23 Sep 2026; present: 3 promoters and 46 others; votes counted by Kanwaljit Singh / Kanwaljit Singh.The company's voting result (opens in a new tab)
- To receive, consider and adopt the Audited Financial Statements for the financial year ended 31st March, 2026, together with the Reports of the Board of Directors and Auditors thereonOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 63.67% · promoters 89.70% · institutions 0.00% · other public 18.69%
- To appoint a Director in place of Mr. Ranjan Jain (DIN: 00635274), who retires by rotation and, being eligible, offers himself for re-appointment.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 61.25% · promoters 89.70% · institutions 0.00% · other public 12.04%
- To consider the appointment of Auditor in case of Casual Vacancy and fix their remunerationOrdinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 63.67% · promoters 89.70% · institutions 0.00% · other public 18.69%
- To consider the appointment of Auditor and fix their remuneration.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 63.67% · promoters 89.70% · institutions 0.00% · other public 18.69%
- To approve material related party transactions with M/s Pharmacare International for a period of one year from 33rd Annual General Meeting till 34th Annual General Meeting.OrdinaryPromoters have an interest in it99.10% for0.90% against
Against: promoters 0.00% · institutions 0.00% · other public 0.90%
Turnout: all 6.88% · promoters 0.00% · institutions 0.00% · other public 18.86%
- To approve material related party transactions with M/s Indosol Export for a period of one year from 33rd Annual General Meeting till 34th Annual General Meeting.OrdinaryPromoters have an interest in it99.10% for0.90% against
Against: promoters 0.00% · institutions 0.00% · other public 0.90%
Turnout: all 6.88% · promoters 0.00% · institutions 0.00% · other public 18.86%
- To approve material related party transactions with M/s JB Khikhani & Co. for a period of one year from 33rd Annual General Meeting till 34th Annual General MeetingOrdinaryPromoters have an interest in it99.10% for0.90% against
Against: promoters 0.00% · institutions 0.00% · other public 0.90%
Turnout: all 6.88% · promoters 0.00% · institutions 0.00% · other public 18.86%
- To approve and ratify the remuneration of the Cost Auditor for the financial year 2026-27.Ordinary100.00% for0.00% against
Against: promoters 0.00% · institutions 0.00% · other public 0.00%
Turnout: all 63.67% · promoters 89.70% · institutions 0.00% · other public 18.69%
- To ratify continuation of Corporate Guarantee in respect of credit facilities availed by M/s Pharmacare International, a partnership concern.Ordinary99.90% for0.10% against
Against: promoters 0.00% · institutions 0.00% · other public 0.90%
Turnout: all 63.73% · promoters 89.70% · institutions 0.00% · other public 18.86%
- To consider the appointment and re-designation of Mr. Ranjan Jain as Whole-Time Director and fix their remuneration.Special96.01% for3.99% against
Against: promoters 0.00% · institutions 0.00% · other public 36.98%
Turnout: all 63.73% · promoters 89.70% · institutions 0.00% · other public 18.86%
- To consider the appointment and re-designation of Mr. Suninder Veer Singh as Managing Director and fix their remuneration.Special96.01% for3.99% against
Against: promoters 0.00% · institutions 0.00% · other public 36.98%
Turnout: all 63.73% · promoters 89.70% · institutions 0.00% · other public 18.86%
For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.
Investor complaints and compliance
Quarter by quarter.
Investor complaints received and resolved, the company's own count
- Received
- Resolved
Open at the quarter's end
- The board is made up as the listing rules require
- Yes
- The board has a regular chairperson
- Yes
- The company has a risk management committee
- No
- The chair is related to the managing director
- No
- The filing has a part on fines and penalties
- No
- The filing has a part on tax disputes
- No
- There was a cyber security incident in the quarter
- No
The company's own answers in its filing.
How money raised was used
Reported for the quarter to Mar 2026. The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it. A preferential issue sells new shares to chosen investors rather than to the public. A warrant or partly paid issue plans the whole issue while the money comes in over time, so the amount set aside can be more than raised so far.
| Raised | Amount raised | For | Set aside | Spent | Spent elsewhere | Reason and comments |
|---|---|---|---|---|---|---|
| Preferential IssuesMar 2026 | 20.21 | To Repayment of Security Deposit | 24.35 | 0.00 | No | Audit committee: Transaction Approved by Audit CommitteeAuditors: Transaction verifield by the Auditor to be as per the information |
| Preferential IssuesMar 2026 | 20.21 | To Meet Capex Requirement | 5.00 | 0.00 | No | Audit committee: Transaction Approved by Audit CommitteeAuditors: Transaction verifield by the Auditor to be as per the information |
| Preferential IssuesMar 2026 | 20.21 | To Meet working capital requirement of the company | 50.00 | 20.21 | No | Audit committee: Transaction Approved by Audit CommitteeAuditors: Transaction verifield by the Auditor to be as per the information |
| Preferential IssuesMar 2026 | 20.21 | General Corporate Purpose | 2.48 | 0.00 | No | Audit committee: Transaction Approved by Audit CommitteeAuditors: Transaction verifield by the Auditor to be as per the information |
| Preferential IssuesMar 2026 | 20.21 | Total | 81.83 | 20.21 | No | Audit committee: Transaction Approved by Audit CommitteeAuditors: Transaction verifield by the Auditor to be as per the information |